Academic Journal

Multi-Targeting Approach in Glioblastoma Using Computer-Assisted Drug Discovery Tools to Overcome the Blood–Brain Barrier and Target EGFR/PI3Kp110β Signaling

التفاصيل البيبلوغرافية
العنوان: Multi-Targeting Approach in Glioblastoma Using Computer-Assisted Drug Discovery Tools to Overcome the Blood–Brain Barrier and Target EGFR/PI3Kp110β Signaling
المؤلفون: Catarina Franco, Samina Kausar, Margarida F. B. Silva, Rita C. Guedes, Andre O. Falcao, Maria Alexandra Brito
المصدر: Cancers; Volume 14; Issue 14; Pages: 3506
بيانات النشر: Multidisciplinary Digital Publishing Institute
سنة النشر: 2022
المجموعة: MDPI Open Access Publishing
مصطلحات موضوعية: blood–brain barrier, dual-targeting, epidermal growth factor receptor, glioblastoma, phosphatidylinositol-3-kinase, quantitative structure–activity relationship models, virtual screening
الوصف: The epidermal growth factor receptor (EGFR) is upregulated in glioblastoma, becoming an attractive therapeutic target. However, activation of compensatory pathways generates inputs to downstream PI3Kp110β signaling, leading to anti-EGFR therapeutic resistance. Moreover, the blood–brain barrier (BBB) limits drugs’ brain penetration. We aimed to discover EGFR/PI3Kp110β pathway inhibitors for a multi-targeting approach, with favorable ADMET and BBB-permeant properties. We used quantitative structure–activity relationship models and structure-based virtual screening, and assessed ADMET properties, to identify BBB-permeant drug candidates. Predictions were validated in in vitro models of the human BBB and BBB-glioma co-cultures. The results disclosed 27 molecules (18 EGFR, 6 PI3Kp110β, and 3 dual inhibitors) for biological validation, performed in two glioblastoma cell lines (U87MG and U87MG overexpressing EGFR). Six molecules (two EGFR, two PI3Kp110β, and two dual inhibitors) decreased cell viability by 40–99%, with the greatest effect observed for the dual inhibitors. The glioma cytotoxicity was confirmed by analysis of targets’ downregulation and increased apoptosis (15–85%). Safety to BBB endothelial cells was confirmed for three of those molecules (one EGFR and two PI3Kp110β inhibitors). These molecules crossed the endothelial monolayer in the BBB in vitro model and in the BBB-glioblastoma co-culture system. These results revealed novel drug candidates for glioblastoma treatment.
نوع الوثيقة: text
وصف الملف: application/pdf
اللغة: English
Relation: Transplant Oncology and Cancer Nursing Care; https://dx.doi.org/10.3390/cancers14143506
DOI: 10.3390/cancers14143506
الاتاحة: https://doi.org/10.3390/cancers14143506
Rights: https://creativecommons.org/licenses/by/4.0/
رقم الانضمام: edsbas.EE3B132
قاعدة البيانات: BASE